
OPCH Stock Forecast & Price Target
OPCH Analyst Ratings
Bulls say
Option Care Health Inc. demonstrated strong financial performance with gross profit reaching $269.0 million, reflecting an 8% year-over-year growth, surpassing estimates. The company's chronic therapy business also exhibited robust expansion, growing at over 10%. Furthermore, Option Care Health increased its 2025 revenue outlook to a range of $5.5 billion to $5.65 billion, representing a 12% year-over-year growth at the midpoint, alongside raised guidance for adjusted financial metrics.
Bears say
The financial outlook for Option Care Health Inc appears negative due to several key factors impacting its profitability and revenue stability. A significant concern is the reliance on a single largest customer, which contributed 14% of the company's 2023 revenue; losing this client could substantially harm overall revenue and profitability. Additionally, limitations on gross margin expansion stem from the faster growth of lower-margin chronic therapies compared to higher-margin acute therapies, which poses a challenge for future EBITDA margin improvement amid projected gross profit headwinds associated with the Stelara item.
This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.
OPCH Analyst Forecast & Price Prediction
Start investing in OPCH
Order type
Buy in
Order amount
Est. shares
0 shares